Trailing-twelve-month (TTM) revenue is $60.84 Million with a year-over-year growth of +4.62%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $14,005,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-10 |
| Q4 FY2025Period ended 2025-12-31 | $17,380,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-09 |
| Q1 FY2026Period ended 2026-03-31 | $13,381,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q2 FY2026Period ended 2026-06-30 | $16,074,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-11 |
| TTM revenue | $60,840,000 |
Current P/S: $504,839,696 market capitalization ÷ $60,840,000 TTM revenue = 8.30x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T19:55:07.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $16.07M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:57:44.332Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|
| Consumables and service | $8M | $16M | N/A | N/A | N/A |
| Contract | N/A | N/A | $370,000 | $317,000 | $117,000 |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|
| Americas other | N/A | $76,000 | $853,000 | $860,000 | $2M |
| Asia Pacific | N/A | $3M | $2M | $3M | $3M |
| Europe, Middle East and Africa |
$60.84M
$60.84 Million
+4.62%
vs. $58.15M a year ago (TTM)
+18.92%
5 Year compound annual growth rate
1 Year
+4.62%
3 Year
+7.46%
5 Year
+18.92%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $56.20M | ($3.43M) | (5.76%) |
| 2024 | $59.63M | +$9.40M | +18.72% |
| 2023 | $50.23M | +$3.38M | +7.21% |
| 2022 | $46.85M | +$4.65M | +11.01% |
| 2021 | $42.21M | +$15.31M | +56.93% |
| 2020 |
TTM Growth
+4.62%
3-Year CAGR
+7.46%
5-Year CAGR
+18.92%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 26 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T19:57:44.332Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| Device sales | $33M | $29M | N/A | N/A | N/A |
|---|
| Device Sales | N/A | N/A | $33M | $36M | $37M |
|---|
| License and contract revenue | $1M | $2M | N/A | N/A | N/A |
|---|
| Product and service revenue | $15M | $17M | $50M | $60M | $7M |
|---|
| Recurring | N/A | N/A | $16M | $23M | $19M |
|---|
| $4M |
| $6M |
| $9M |
| $13M |
| $10M |
| UNITED STATES | N/A | $38M | $38M | $42M | $41M |
|---|
| $26.89M |
| +$8.92M |
| +49.64% |
| 2019 | $17.97M | ($4.08M) | (18.51%) |
